Verition Fund Management’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.1M Buy
17,989
+8,484
+89% +$1.57M 0.03% 783
2025
Q4
$1.9M Sell
9,505
-201
-2% -$36.5K 0.01% 1656
2025
Q3
$1.52M Sell
9,706
-20,345
-68% -$3.23M 0.01% 2202
2025
Q2
$4.56M Buy
30,051
+22,940
+323% +$3.06M 0.03% 1221
2025
Q1
$1.07M Sell
7,111
-7,268
-51% -$1.22M 0.01% 2076
2024
Q4
$2.65M Buy
+14,379
New +$2.77M 0.01% 1370
2024
Q3
Sell
-1,141
Closed -$236K 3247
2024
Q2
$236K Buy
+1,141
New +$259K ﹤0.01% 2496
2023
Q1
Sell
-1,629
Closed -$355K 2223
2022
Q4
$355K Sell
1,629
-318
-16% -$69.4K 0.01% 1412
2022
Q3
$383K Sell
1,947
-505
-21% -$109K 0.01% 2060
2022
Q2
$525K Buy
+2,452
New +$599K 0.01% 1418
2020
Q4
Sell
-1,919
Closed -$435K 1154
2020
Q3
$435K Sell
1,919
-3,469
-64% -$720K 0.01% 623
2020
Q2
$939K Buy
+5,388
New +$860K 0.04% 430
2019
Q4
Sell
-1,540
Closed -$204K 1120
2019
Q3
$204K Buy
+1,540
New +$206K 0.01% 946
2019
Q2
Sell
-3,762
Closed -$546K 1117
2019
Q1
$546K Sell
3,762
-2,887
-43% -$379K 0.03% 622
2018
Q4
$753K Buy
6,649
+1,518
+30% +$190K 0.06% 324
2018
Q3
$690K Buy
+5,131
New +$633K 0.03% 711
2018
Q2
Sell
-2,298
Closed -$245K 1121
2018
Q1
$245K Buy
+2,298
New +$248K 0.02% 910
2017
Q2
Sell
-6,495
Closed -$584K 980
2017
Q1
$584K Buy
6,495
+3,124
+93% +$265K 0.06% 484
2016
Q4
$257K Buy
3,371
+334
+11% +$25.4K 0.03% 910
2016
Q3
$253K Buy
+3,037
New +$255K 0.03% 869
2016
Q1
Sell
-12,592
Closed -$1.01M 723
2015
Q4
$1.01M Buy
+12,592
New +$908K 0.21% 101
2015
Q3
Sell
-3,697
Closed -$260K 558
2015
Q2
$260K Sell
3,697
-820
-18% -$60.7K 0.06% 361
2015
Q1
$358K Buy
+4,517
New +$333K 0.1% 154

Other funds holding CRL